🇺🇸 FDA
Patent

US 8492397

Aminopyridine derivatives having Aurora A selective inhibitory action

granted A61PA61P35/00A61P43/00

Quick answer

US patent 8492397 (Aminopyridine derivatives having Aurora A selective inhibitory action) held by Vertex Pharmaceuticals Incorporated expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jul 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61P, A61P35/00, A61P43/00